RE: RNS out15 Nov 2023 08:20
Micky - keep bleating if you like.
I simply made an observation - you could be Mickey Mouse for all i know
I simply don't trust those that invite a troll to post/respond on here - what possible value is there from that?
Equally, I could be donald duck. If you wanted a genuine answer about Prevail, Cash and likelihood of a placing you would be far better asking someone who over a period of time has proved genuine.
HEMO HAVE PUBLICLY STATED (IN RNS) THAT THEY INTEND TO RAISE ADDITIONAL FUNDING AHEAD OF CLINICAL TRIALS. WE HAVE ALL KNOW THAT FOR WEEKS!!!!! It's not clear to me if that is ahead of Phase 1 or perhaps slightly after.
The view I have taken, is that Prevail have invested after a robust, detailed due diligence process. They appear to be leading on behalf of Hemo to raise additional duns - they are well respected and well connected. Other Biotech investors are likely to follow suit given Prevail's credibility and validation of Hemogenyx.
So, i think it is most likely we see funding led by Prevail
The alternative is a more standard placing like we have seen in the past - I would be surprised if Hemo took this route and if they do I would be even more surprised if they raised at this share price. I think they would wait until after the CH is lifted, trials ready to start and possibly a market update on CBR.